Assessment shows chlortetracycline-loaded collagen sponges effectively deliver drugs, suggesting enhanced healing in dental applications.
Collagen-based biomaterials are increasingly explored in dentistry for their ability to deliver drugs locally and support healing. In this study, we developed chlortetracycline-loaded collagen sponges aimed at preventing postoperative infections. Five formulations were prepared by lyophilization, each with the same collagen-to-drug ratio but different glutaraldehyde (GA) concentrations: 0%, 0.25%, 0.5%, 0.75%, and 1% (w/w) relative to dry collagen. The sponges were characterized using FT-IR and UV–VIS–NIR spectroscopy, and their swelling capacity, enzymatic stability, and drug release kinetics were evaluated. Antibacterial activity was tested against Escherichia coli, Staphylococcus aureus, and Enterococcus faecalis. Statistical differences between formulations were assessed using one-way ANOVA followed by Tukey’s post hoc test (p < 0.05). All sponges released the antibiotic rapidly within the first 60 min, followed by a sustained release for up to 10 h. The non-crosslinked sponge showed the highest antimicrobial effect, while the 0.25% GA formulation offered a good balance between stability and bioactivity. While higher cross-linking enhanced structural stability, it progressively reduced antimicrobial efficacy, highlighting a crucial design trade-off. These findings underline the need to fine-tune cross-linking conditions to achieve both durability and strong antimicrobial action in collagen-based drug delivery systems for dental applications.
No takes yet. Share an insight, caveat, or question.
Tihan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: